Open Payments

The University of Vermont Medical Center Inc.

Type
Non-covered entity
Where
Burlington, VT
Received
$41,708 in 15 records, 2021 to 2023 ($0 general, $41,708 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2023Research payment2$10,247
2022Research payment11$26,463
2021Research payment2$4,997

By company

CompanyRecordsAmountYears
Apellis Pharmaceuticals, Inc.13$31,4612021–2022
Bausch Health US, LLC2$10,2472023

By nature of payment

NatureRecordsAmount
Research payment15$41,708

Records

DateCompanyAmountNatureFormProductStudyYear
2023-11-17Bausch Health US, LLC$3,500Research paymentCash or cash equivalentXIFAXAN Drug, GastroenterologyStudy to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RE2023
2023-11-15Bausch Health US, LLC$6,747Research paymentCash or cash equivalentXIFAXAN Drug, GastroenterologyStudy to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RE2023
2022-12-21Apellis Pharmaceuticals, Inc.$217Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-11-22Apellis Pharmaceuticals, Inc.$2,500Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-10-19Apellis Pharmaceuticals, Inc.$2,684Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-10-19Apellis Pharmaceuticals, Inc.$266Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-10-07Apellis Pharmaceuticals, Inc.$2,674Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-08-05Apellis Pharmaceuticals, Inc.$2,457Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-06-20Apellis Pharmaceuticals, Inc.$217Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-06-07Apellis Pharmaceuticals, Inc.$3,900Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-05-20Apellis Pharmaceuticals, Inc.$3,159Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-04-20Apellis Pharmaceuticals, Inc.$8,056Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-01-07Apellis Pharmaceuticals, Inc.$330Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2021-12-07Apellis Pharmaceuticals, Inc.$598Research paymentCash or cash equivalentMERIDIAN2021
2021-11-19Apellis Pharmaceuticals, Inc.$4,399Research paymentCash or cash equivalentMERIDIAN2021

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Chittenden CountyBurlington city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Burlington, VT, county Chittenden County, VT, state Vermont; placed by its city name.

MeasurePlace (city or town)
Burlington, VT
County
Chittenden County, VT
State
Vermont
Population B0100344,675169,758647,106
Population, 2020 census P144,743168,323643,077
Median age B0100226.837.343.1
Under 18 B0100111.1%17.2%17.9%
65 and over B0100112.1%16.9%21.4%
Households B1100117,50471,456273,416
Foreign born B050027.1%7.9%4.3%
Median household income B19013$71,109$96,759$81,203
Median family income B19113$130,243$131,883$105,211
Per capita income B19301$40,192$52,322$46,500
Poverty rate B1700120.5%9.7%10.1%
Unemployment rate B230254.3%3.2%3.6%
Civilian labor force B2302526,390101,136352,132
Mean commute (minutes) B0801318.721.123.5
Bachelor's degree or higher B1500360.5%56.8%43.8%
Housing units B2500118,07974,888339,042
Owner-occupied B2500341.5%63.9%73.2%
Renters B2500358.5%36.1%26.8%
Median home value B25077$444,800$439,200$316,600
Median gross rent B25064$1,649$1,646$1,234
White, not Hispanic B0300284.1%85.5%89.9%
Black B030022.9%2.3%1.1%
Hispanic or Latino B030022.8%2.9%2.6%
Asian B030024.2%4.4%1.8%
American Indian and Alaska Native B030020.0%0.1%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Burlington, VT.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.